ArticleThe journal of headache and pain2026
Migraine 1-2-3-4-5: a candidate communication aid for adult migraine without aura.
Article in The journal of headache and pain, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Migraine remains under-recognised despite its substantial global burden. This Correspondence presents Migraine 1-2-3-4-5 as a candidate communication aid for adults aged 18 years or older with recurrent headache. It reorganises selected positive clinical features of migraine without aura from the International Classification of Headache Disorders, third edition (ICHD-3), into five numerical anchors spanning four clinical domains: one associated-symptom category, at least two headache features, one 4-72-hour duration condition jointly encoded by 3 days and 4 h, and at least five attacks. Its proposed value is a compact, visible structure for discussing clinically relevant history before or during a clinical encounter; whether it improves comprehension, recall, or reporting is unknown. It is not a questionnaire, score, diagnostic rule, or exclusion rule. Interpretation requires several caveats: successfully treated attacks may be shorter than 4 h; fewer than five otherwise typical attacks may meet criteria for probable migraine without aura; and new, sudden, progressive, atypical, or concerning headache requires clinical assessment. This is a conceptual article; no participants were enrolled and no outcomes were measured. Validation should proceed hierarchically from comprehension, recall, and accurate symptom reporting to communication outcomes, followed by diagnostic-concordance and safety outcomes. Comparative usability testing against an information-matched plain-language presentation is required before routine public use can be recommended.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.